Notícias Eulerpool Theratechnologies

Theratechnologies Notícias de ações

Theratechnologies é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Theratechnologies nós reunimos aqui.

• 9 de janeiro ·

  Yahoo
  Theratechnologies Provides Update on EGRIFTA SV® Supply
• 10 de dezembro ·

  Yahoo
  Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA
• 9 de dezembro ·

  Yahoo
  Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer
• 4 de dezembro ·

  Yahoo
  Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada
• 26 de novembro ·

  Yahoo
  Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review
• 25 de novembro ·

  Yahoo
  Theratechnologies Inc. (TSE:TH) Has Found A Path To Profitability
• 17 de outubro ·

  Yahoo
  Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab
• 17 de outubro ·

  Yahoo
  Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance
• 11 de outubro ·

  Yahoo
  Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
• 10 de outubro ·

  Yahoo
  Theratechnologies Up 12% in U.S. Premarket Trading After Reporting Q3 Swing to Profit